Heterozygous carrier of G20210A prothrombin mutation used oral contraceptive treatment for 23 years without thrombotic events, and developed cerebral venous thrombosis 1 month after resumption of the medication at the age of 50.
Tormene
D
D
Simioni
P
P
Sartori
M T
MT
Girolami
A
A
D002550:Cerebral Veins; D003276:Contraceptives, Oral / Q000008:administration & dosage / Q000009:adverse effects*; D005260:Female; D006579:Heterozygote; D006801:Humans; D020767:Intracranial Thrombosis / Q000209:etiology*; D008875:Middle Aged; D009154:Mutation; D011247:Pregnancy; D011516:Prothrombin / Q000235:genetics*
D003276:Contraceptives, Oral; D011516:Prothrombin